Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major.

Iniguez EA, Perez A, Maldonado RA, Skouta R. Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major. Bioorg Med Chem Lett. 2015 Nov 15; 25(22):5315-20.

View in: PubMed

authors with profiles

Rosa A. Maldonado

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support